ID   NOS2
AC   CVCL_T747
SY   NOS-2; Nagoya Ovarian Serous 2
DR   BTO; BTO_0004923
DR   Wikidata; Q54930916
RX   PubMed=8097673;
RX   PubMed=9344045;
RX   PubMed=12767062;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 8
CH   CVCL_RN33 ! NOS2AR
CH   CVCL_RN29 ! NOS2CR
CH   CVCL_RN30 ! NOS2SNR
CH   CVCL_RN31 ! NOS2VR
//
RX   PubMed=12767062; DOI=10.1002/ijc.11177;
RA   Kikkawa, Fumitaka
RA   Kajiyama, Hiroaki
RA   Ino, Kazuhiko
RA   Shibata, Kiyosumi
RA   Mizutani, Shigehiko
RT   "Increased adhesion potency of ovarian carcinoma cells to mesothelial
RT   cells by overexpression of dipeptidyl peptidase IV.";
RL   Int. J. Cancer 105:779-783(2003).
//
RX   PubMed=9344045; DOI=10.1023/A:1018495414975;
RA   Shibata, Kiyosumi
RA   Kikkawa, Fumitaka
RA   Nawa, Akihiro
RA   Tamakoshi, Koji
RA   Suganuma, Nobuhiko
RA   Tomoda, Yutaka
RT   "Increased matrix metalloproteinase-9 activity in human ovarian cancer
RT   cells cultured with conditioned medium from human peritoneal tissue.";
RL   Clin. Exp. Metastasis 15:612-619(1997).
//
RX   PubMed=8097673;
RA   Maeda, Osamu
RA   Terasawa, Motomu
RA   Ishikawa, Tomohiko
RA   Oguchi, Hidenori
RA   Mizuno, Kimio
RA   Kawai, Michiyasu
RA   Kikkawa, Fumitaka
RA   Tomoda, Yutaka
RA   Hidaka, Hiroyoshi
RT   "A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin
RT   activity against human ovarian carcinoma cells.";
RL   Cancer Res. 53:2051-2056(1993).
//